Richard Resnick
Chief Executive Officer (blog)
Resnick has led GenomeQuest’s products and services operations since 2008. He has extensive experience building and growing innovative technology companies in the life sciences. He was previously CEO of Mosaic Bioinformatics, which was sold to NetGenics. Prior to Mosaic, Resnick was global bioinformatics software head for Wyeth, and, before that, a member of the Human Genome Project under Eric Lander at MIT. Resnick holds an M.B.A. from the Sloan School at MIT, an M.S. in Computer Science from WPI, and a B.S. in Computer Science from UMass Amherst.
Dr. Jean-Jacques Codani
Chief Scientific Officer, Director and Founder
Dr. Codani provides the GenomeQuest’s technology vision and direction. For over a decade he has been a leading innovator in the development of the core technologies used to implement GenomeQuest. Prior to his association with GenomeQuest he lead a four year research program on large scale sequence search at the French National Research Institute for Computer Science and Control (INRIA). Before that he was instrumental in developing the computational tools necessary for the physical mapping of the human genome at the Genethon/CEPH.
Dr. Drew Arnold, Ph.D.
Senior Vice President of Worldwide Sales
Dr. Arnold leads GenomeQuest’s global sales team. Drew joined GenomeQuest in 2006 as head of strategic accounts, a role in which he was a leader and major contributor to GenomeQuest’s compelling sales successes. He has over 10 years of experience in the life sciences industry, largely in senior business development, management and scientific applications roles. Prior to joining GenomeQuest, Dr. Arnold served as Vice President of Business Development for Silicon Informatics, Inc. Before Silicon Informatics, he was Senior Director, Business Development at LION Bioscience of Cambridge, where he set up US sales and support operations and lead strategic alliances for drug discovery. Dr. Arnold also served as Group Leader, Scientific Applications Managers, for Molecular Applications Group, Inc. He received his Ph.D. in physiology from Cornell University in 1993 and also has degrees from Oregon State University and the University of Minnesota.
Dr. Henk Heus, Ph.D.
Vice President of Product Management & Professional Services (blog)
With GenomeQuest since 2001, Dr. Heus’ role has evolved from Field Application Scientist, working directly with customers to solve immediate problems, to his current role, more focused on use cases and methodologies for personalized medicine. The combination of Dr. Heus’s rich background in molecular biology and his software development expertise enables him to understand and manage the GQ-PMR (Personalized Medicine Research) program’s steering committee and collaborative efforts.
Dr. Heus holds a PhD in human genetics from the Erasmus Medical Center, Department of Clinical Genetics. With over 15 years experience in genomics, including at NV Organon/Akzo Nobel, he brings expertise and invention from all fields critical to GQ-PMR and its members: the pure science of genomics, its application to research and clinical work, the incorporation of large genomic datasets and multi-genome analysis to realize comparative biology, and the underlying software and hardware informatics infrastructure to enable and support PMR.
Deirdre O. Aubuchon
Chief Financial Officer
As chief financial officer, Deirdre Aubuchon is responsible for GenomeQuest’s worldwide financial operations ensuring that the company maintains the financial infrastructure necessary to successfully execute the company’s strategic plan. She brings to GenomeQuest over 20 years of financial leadership helping to build fast-growing technology companies. Aubuchon most recently served as Deploy Solutions’ chief financial and operating officer when the SaaS company achieved five consecutive years of more than 50% annual revenue growth while earning both local and national Best Places to Work awards prior to selling the company to Kronos, Inc. Before Deploy, Deirdre served as vice president of finance for ZEFER, where she led the company’s IPO process after building the infrastructure to grow the company to 800 employees with $110 million of revenue in less than two years. Prior to joining ZEFER, she was vice president of corporate finance at Liberty International where she directed worldwide M&A activity. She has also held senior-level positions in finance with Berlitz International, Standard & Poor’s, and Dun & Bradstreet Software. Aubuchon is a graduate of the University of New Hampshire and holds an MBA in finance and accounting from the University of Massachusetts, Amherst.
Anthony Flynn
Chief Marketing Officer (blog)
Flynn, who serves as chief marketing officer (CMO) has a 20-year history of helping shape and develop new markets and increase sales in high technology. His previous assignments include CMO at Bentley Systems, Inc., a provider of engineering software to the global infrastructure market which grew from $27M to $450M during his span with the company. Flynn also served in marketing management for two start-ups in the electronic design automation (EDA) that each achieved IPO and market leadership. Prior to joining GenomeQuest as CMO, he served the company in a consulting role for one year — a period which saw marketing metrics rise by over fifty percent. Flynn received his Bachelor of Science degree in Mathematics with minors and post-graduate work in Computer Science and EE from the University of Alabama at Huntsville.
